"A recent op-ed describes the story of an author who, after using a compounded injectable GLP-1 medication, experienced acute liver failure and required an emergency liver transplant due to severe drug-induced injury."
"Almost one in eight adults in the United States reports having tried a GLP-1 medication, with 40 percent using them for weight loss and a similar proportion for chronic conditions."
"Many respondents reported obtaining GLP-1 medications from unregulated sources like weight-loss clinics and online providers, raising concerns about safety and efficacy."
"Without insurance, a one-month supply of brand-name GLP-1 medications can cost between $900 and $1,000, prompting individuals to seek compounded alternatives despite potential risks."
Compounded GLP-1 medications are increasingly used for weight loss and chronic conditions, but they pose significant safety risks due to lack of regulation. A case study highlights a patient who suffered acute liver failure after using a compounded version instead of a brand-name medication. Many individuals report using these medications without proper prescriptions, often due to insurance issues. The high costs of brand-name GLP-1 medications lead some to seek alternatives, increasing the risk of adverse effects from unregulated sources.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]